"Urothelial cell cancer" trang 1 - tải miễn phí từ tailieunhanh
Protein kinase C-α (PKCα) modulates cell apoptosis by stimulating nuclear translocation of NF-kappa-B p65 in urothelial cell carcinoma of the bladder

Protein kinase C-α (PKCα) modulates cell apoptosis by stimulating nuclear translocation of NF-kappa-B p65 in urothelial cell carcinoma of the bladder
12    86    1
Isolation and in vitro cultivation of human urothelial cells from urine of patients

Isolation and in vitro cultivation of human urothelial cells from urine of patients
8    6    1
Serum Hepcidin and GDF-15 levels as prognostic markers in urothelial carcinoma of the upper urinary tract and renal cell carcinoma

Serum Hepcidin and GDF-15 levels as prognostic markers in urothelial carcinoma of the upper urinary tract and renal cell carcinoma
10    78    0
Elevated levels of MMP12 sourced from macrophages are associated with poor prognosis in urothelial bladder cancer

Elevated levels of MMP12 sourced from macrophages are associated with poor prognosis in urothelial bladder cancer
13    1    1
Effect of HMGB1 polymorphisms on urothelial cell carcinoma susceptibility and clinicopathological characteristi

Effect of HMGB1 polymorphisms on urothelial cell carcinoma susceptibility and clinicopathological characteristi
6    78    0
TUBA1C is a potential new prognostic biomarker and promotes bladder urothelial carcinoma progression by regulating the cell cycle

TUBA1C is a potential new prognostic biomarker and promotes bladder urothelial carcinoma progression by regulating the cell cycle
12    1    1
Prognostic value of TOP2A in bladder urothelial carcinoma and potential molecular mechanisms

Prognostic value of TOP2A in bladder urothelial carcinoma and potential molecular mechanisms
12    78    0
Comprehensive gene expression analysis of canine invasive urothelial bladder carcinoma by RNA-Seq

Comprehensive gene expression analysis of canine invasive urothelial bladder carcinoma by RNA-Seq
11    34    1
Predominant global glomerulosclerosis in patients of upper urinary tract urothelial carcinoma with pre-existing renal function impairment is a predictor of poor renal outcomes

Predominant global glomerulosclerosis in patients of upper urinary tract urothelial carcinoma with pre-existing renal function impairment is a predictor of poor renal outcomes
10    68    1
Safety and effectiveness of vinflunine in patients with metastatic transitional cell carcinoma of the urothelial tract after failure of one platinum-based systemic therapy in clinical practice

Safety and effectiveness of vinflunine in patients with metastatic transitional cell carcinoma of the urothelial tract after failure of one platinum-based systemic therapy in clinical practice
9    74    1
Radiation therapy before radical cystectomy combined with immunotherapy in locally advanced bladder cancer – study protocol of a prospective, single arm, multicenter phase II trial (RACE IT)

Radiation therapy before radical cystectomy combined with immunotherapy in locally advanced bladder cancer – study protocol of a prospective, single arm, multicenter phase II trial (RACE IT)
9    85    0
Chromosomal imbalances in human bladder urothelial carcinoma: Similarities and differences between biopsy samples and cancer stem-like cells

Chromosomal imbalances in human bladder urothelial carcinoma: Similarities and differences between biopsy samples and cancer stem-like cells
10    39    1
PARP inhibitors chemopotentiate and synergize with cisplatin to inhibit bladder cancer cell survival and tumor growth

PARP inhibitors chemopotentiate and synergize with cisplatin to inhibit bladder cancer cell survival and tumor growth
14    20    1
HSDL2 promotes bladder cancer growth in vitro and in vivo

HSDL2 promotes bladder cancer growth in vitro and in vivo
6    91    0
Real-life clinical practice results with vinflunine in patients with relapsed platinum-treated metastatic urothelial carcinoma: An Italian multicenter study (MOVIE-GOIRC 01–2014)

Real-life clinical practice results with vinflunine in patients with relapsed platinum-treated metastatic urothelial carcinoma: An Italian multicenter study (MOVIE-GOIRC 01–2014)
10    78    1